Margin resik Accelerate Diagnostics Inc. (AXDX)

Tandha merek Accelerate Diagnostics, Inc. (AXDX)

Accelerate Diagnostics (AXDX) generates revenue through the sale of infection recognition automation and consumable cartridges. Relative net sales on the precise GURU.Markets service chart shows that the current level is 0.00. Growth is driven by hospital demand for rapid bacteremia tests and M&A, although expansion is constrained by the high cost of equipment, which necessitates subsidized leasing to capture market share.

Accelerate Diagnostics (AXDX) - Margin resik saka 04.07.2022 nganti 24.05.2025

AXDX (Accelerate Diagnostics): rincian analitis lan laporan miturut indikator

Pambiji fundamental perusahaan:Accelerate Diagnostics Inc - AXDX
Barang unggulan Accelerate Diagnostics Inc

A comparative asset analysis requires an assessment of a business's ability to convert revenue into actual profit. This indicator measures the remaining funds after all expenses are deducted, determining overall operational resilience. High laboratory confidence in the accuracy of Accelerate Diagnostics (AXDX) systems allows the company to optimize its pricing power. The stability of net income per unit of sales confirms effective capital management. Investors should use this chart to monitor the protection of assets against degradation.

Analisis perusahaan pesaing

A (Agilent Technologies) - Rentabilitas dodolan miturut bathi resik|DGX: Rentabilitas resik perusahaan|Margin resik Illumina Platform|EXAS (Exact Sciences) - Rentabilitas resik perusahaan|Rentabilitas dodolan miturut bathi resik RVTY (PerkinElmer)|Bio-Rad - Rentabilitas dodolan resik|Margin dodolan resik NNNN (Anbio)|Tingkat bathi resik SHC|QDEL - Margin resik|OPK: Margin resik|caredx.com (CDNA) - Margin resik|MRVI (Maravai LifeSciences) - Margin resik|FLGT (Fulgent) - Margin dodolan resik|Standard BioTools Inc (LAB) - Margin dodolan perusahaan|Margin dodolan resik CTKB|Rentabilitas dodolan miturut bathi resik OraSure Technologies Inc OSUR|Margin dodolan resik XGN (Exagen Diagnostics)|Margin dodolan resik mdxhealth.com MDXH|LUCD - Margin resik|PRE: Margin resik|IMDX (Insight Molecular Diagnostics Inc) - Rentabilitas dodolan miturut bathi resik|Rentabilitas dodolan miturut bathi resik Trinity Biotech PLC|PRPH (prophaselabs.com) - Margin dodolan resik|Rentabilitas dodolan miturut bathi resik Ainos, Inc. (AIMD)|Margin dodolan resik CODX|HSCS (HeartSciences) - Tingkat bathi resik|Margin resik Biomerica, Inc BMRA|CDIO - Rentabilitas dodolan miturut bathi resik|ONCO - Margin resik|VRAX - Margin dodolan resik|Bluejay Diagnostics Inc (BJDX) - Margin resik|Aspira Women's Health Inc. - Tingkat bathi resik|CNTG (CENTOGENE N.V.) - Margin dodolan resik|Rentabilitas dodolan miturut bathi resik Enzo Biochem, Inc. (ENZ)|FRES - Margin bathi resik|Genetic Technologies Limited (GENE) - Tingkat bathi miturut bathi resik|Margin dodolan resik ME (23andme.com)|Psychemedics Corp. (PMD) - Margin resik